Baird Medical Investment Holdings Limited (NASDAQ:BDMD) Stock Short Interest Jumps 858.6%

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) was the recipient of a large growth in short interest in October. As of October 30th, there was short interest totaling 217,561 shares, a growth of 858.6% from the October 15th total of 22,695 shares. Based on an average daily trading volume, of 1,165,388 shares, the days-to-cover ratio is presently 0.2 days. Currently, 2.4% of the company’s stock are sold short.

Analyst Ratings Changes

Separately, Weiss Ratings cut Baird Medical Investment from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, October 6th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, Baird Medical Investment has a consensus rating of “Sell”.

Baird Medical Investment Price Performance

Baird Medical Investment stock opened at $0.11 on Friday. Baird Medical Investment has a 52-week low of $0.07 and a 52-week high of $3.70. The firm has a 50-day moving average price of $0.63 and a two-hundred day moving average price of $1.28.

Institutional Trading of Baird Medical Investment

An institutional investor recently bought a new stake in Baird Medical Investment stock. Citadel Advisors LLC acquired a new stake in Baird Medical Investment Holdings Limited (NASDAQ:BDMD) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 54,895 shares of the company’s stock, valued at approximately $63,000. Citadel Advisors LLC owned 0.13% of Baird Medical Investment as of its most recent SEC filing. 19.78% of the stock is currently owned by hedge funds and other institutional investors.

Baird Medical Investment Company Profile

Baird Medical Investment Holdings Limited is a medical device company focused on minimally invasive tumor treatment technologies. Through its operating subsidiaries, the company develops, manufactures and markets microwave ablation systems designed to destroy targeted tissue using heat generated by microwave energy. Its product portfolio includes microwave ablation generators, disposable ablation needles and related accessories. The systems are used primarily in the treatment of thyroid nodules and other solid tumors, with applications that may include liver, breast and other soft-tissue conditions.